Basics Aprea Therapeutics, Inc. IPO Date: September 30, 2019 Sector: Healthcare Industry: Biotech Market Cap: $8.56M Activated in VL: True Average Daily Range Avg Daily Range: $0.36 | 3.74% Avg Daily Range (30 D): $0.06 | 3.80% Avg Daily Range (90 D): $0.10 | 3.94% Institutional Daily Volume Avg Daily Volume: .43M Avg Daily Volume (30 D): .02M Avg Daily Volume (90 D): .02M Trade Size Avg Trade Size (Sh.): 214 Avg Trade Size (Sh.) (30 D): 219 Avg Trade Size (Sh.) (90 D): 195 Institutional Trades Total Inst.Trades: 119 Avg Inst. Trade: $1.73M Avg Inst. Trade (30 D): $.52M Avg Inst. Trade (90 D): $.52M Avg Inst. Trade Volume: .01M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.74M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: 7.56K         News May 14, 2025 @ 12:00 PM Aprea Therapeutics Reports First Quarter 2025 Fina... Source: N/A Jun 21, 2024 @ 12:00 PM Aprea Therapeutics to Host Virtual KOL Event on AP... Source: Aprea Therapeutics Jun 17, 2024 @ 12:30 PM Aprea Therapeutics Announces First Patient Dosed i... Source: Aprea Therapeutics May 28, 2024 @ 12:45 PM Aprea Therapeutics Announces that Safety Review Co... Source: Aprea Therapeutics May 13, 2024 @ 8:01 PM Aprea Therapeutics to Attend the 2024 RBC Capital ... Source: Aprea Therapeutics Financials   TTM Q4 2024 FY 2024 Basic EPS $-.66 $-.47 $-2.35 Diluted EPS $-.66 $-.57 $-2.45 Revenue $ .16M $ .21M $ 1.5M Gross Profit $ $ $ Net Income / Loss $ -3.93M $ -2.89M $ -12.96M Operating Income / Loss $ -4.09M $ -3.23M $ -14.32M Cost of Revenue $ $ $ Net Cash Flow $ M $ -3.38M $ 1.25M PE Ratio     Splits Feb 13, 2023:   20:1 Dec 27, 2018:   1000:1 Sep 13, 2011:   500:1